Related Experiment Video
Updated: Jun 14, 2026

06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.7K
Large language model (ChatGPT) as a support tool for breast tumor board
Vera Sorin1,2,3, Eyal Klang4,5,6,7, Miri Sklair-Levy4,5
1Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel Hashomer, Israel. verasrn@gmail.com.
NPJ Breast Cancer
|May 30, 2023
Summary
Large language models like ChatGPT show promise as decision support tools for breast tumor boards. In 70% of cases, ChatGPT recommendations aligned with expert decisions, indicating potential clinical utility.
Area of Science:
- Oncology
- Artificial Intelligence
- Medical Informatics
Background:
- Large language models (LLMs) are gaining attention in both public and scientific spheres.
- The application of LLMs in clinical decision-making, particularly in oncology tumor boards, is an emerging area of research.
Purpose of the Study:
- To evaluate the efficacy of ChatGPT (specifically GPT-3.5) as a decision support tool for breast cancer tumor boards.
- To compare ChatGPT's management recommendations against final decisions made by a multidisciplinary tumor board.
Main Methods:
- Clinical data from ten breast cancer patients were input into ChatGPT-3.5.
- ChatGPT was prompted to recommend patient management.
- Recommendations were compared to tumor board decisions and independently graded by two senior radiologists on summarization, recommendation, and explanation (1-5 scale).
Main Results:
- ChatGPT's recommendations matched tumor board decisions in 70% of cases.
- Radiologists' mean scores for ChatGPT's summarization, recommendation, and explanation ranged from 3.7 to 4.6.
- The study included patients with invasive ductal carcinoma, ductal carcinoma in-situ, and phyllodes tumor.
Conclusions:
- This proof-of-concept study demonstrates the potential of LLMs as decision support tools in breast tumor boards.
- Clinicians should become familiar with the benefits and risks associated with using LLMs in clinical practice.
- Further research is warranted to explore the integration and validation of LLMs in oncological decision-making processes.

